Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

PHR US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Phreesia, Inc.(PHR US)

$12.61-0.090.71%Ext:$12.99+0.383.05%(Pre-Market · 08:00:30 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Phreesia, Inc. — Company Profile

Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.

Sector
Industrials
Industry
Transportation Infrastructure
Exchange
UN
CEO
Chaim Indig
Headquarters
Wilmington, DE, US
IPO Date
Jul 18, 2019
Employees
1,789
Website
www.phreesia.com

Key Metrics

Price
$10.07
Market Cap
$622.45M
Revenue (TTM)
$130.94M
Net Income (TTM)
$2.96M
EPS (TTM)
0.05
P/E (TTM)
67.78
P/B (TTM)
1.73
Dividend Yield
0.00%
ROE (TTM)
0.83%
ROA (TTM)
0.44%
Operating Margin
5.32%
Beta
0.13

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.

Website
www.phreesia.com
Location
Wilmington, DE, US
Phone888 654 7473
Employees1,789
CEOChaim Indig
Sector
Industrials
Industry
Transportation Infrastructure
IPO DateJul 18, 2019

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(1.3K)

Expand
  • 4Linetsky David26 Oct
  • 4VanDuyn Amy Beth28 Sep
  • 4Roberts Evan28 Sep
  • 4Linetsky David28 Sep
  • 4Indig Chaim28 Sep
  • 4Hui Yvonne28 Sep
  • 4Hoffman Allison C28 Sep
  • 4Gandhi Balaji28 Sep
  • 4VanDuyn Amy Beth22 Sep
  • 4Roberts Evan22 Sep
  • 4Linetsky David22 Sep
  • 4Hoffman Allison C22 Sep
  • 144Hoffman Allison C21 Sep
  • 4Roberts Evan16 Sep
  • 4Linetsky David16 Sep
  • 4VanDuyn Amy Beth16 Sep
  • 4Hoffman Allison C16 Sep
  • 4Linetsky David3 Sep
  • 4VanDuyn Amy Beth3 Sep
  • 4Roberts Evan3 Sep

News

  • Head-To-Head Comparison: Phreesia (NYSE:PHR) & National Research (NASDAQ:NRC)18 Oct
  • Phreesia's Michael Rasbury Named to Becker's 2026 List of Rising Stars: Healthcare Leaders Under 408 Oct
  • Phreesia Named to TIME's 2026 List of the World's Top HealthTech Companies30 Sep
  • Phreesia (NYSE:PHR) General Counsel Allison Hoffman Sells 6,662 Shares of Stock23 Sep
  • Phreesia's ProviderConnect Audiences are Now Available in the DeepIntent Audience Marketplace14 Sep
  • Why Phreesia Stock Got Knocked Down Today8 Sep
  • Why Phreesia Stock Tumbled Today3 Sep
  • These Analysts Revise Their Forecasts On Phreesia After Q2 Results3 Sep
  • Phreesia, Inc. (PHR) Q2 2027 Earnings Call Transcript2 Sep
  • Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates2 Sep
  • Phreesia (PHR) Q2 Earnings and Revenues Lag Estimates2 Sep
  • Phreesia Q2 Earnings Call Highlights2 Sep
  • Phreesia Announces Second Quarter Fiscal 2027 Results2 Sep
  • Deutsche Bank AG Invests $538,000 in Phreesia, Inc. $PHR2 Sep
  • Contrasting DarioHealth (NASDAQ:DRIO) and Phreesia (NYSE:PHR)25 Aug
  • Phreesia, Inc. $PHR Stake Lessened by Dimensional Fund Advisors LP13 Aug
  • Phreesia (NYSE:PHR) Shares Gap Up – Here’s Why9 Aug
  • Phreesia Sets Release Date for Fiscal Second Quarter 2027 Results6 Aug
  • PHREESIA, INC. (NYSE: PHR) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty4 Aug
  • PHREESIA, INC. (NYSE: PHR) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty29 Jul

Mentions in Filings

  • #\*Personalis, Inc. 122,793 1,150,570 Pfizer, Inc. 2,693,155 71,207,018 Phibro Animal Health Corp., Class A 54,849 2,202,187 \*<strong>Phreesia</strong>, Inc. 77,396 1,039,428 \*Praxis Precision Medicines, Inc. 4,257 1,336,698 \*Precision BioSciences, Inc. 3,162 12,522 \*Prestige Consumer Healthcare, Inc. 117,714 7,589,022
    Dimensional ETF TrustPhreesia, Inc.·NPORT-EX - NT NPORT-P - Notification of late filing (portfolio holdings)·Q1 26·13 Aug
  • … and serves as Chair of our Audit Committee and Compensation Committee. Ms. Hoffman is also a member of our Nominating and Corporate Governance Committee. Since August 2020, Ms. Hoffman has served as General Counsel of <strong>Phreesia, Inc.</strong> (NYSE:PHR), a leading provider of software solutions that healthcare organizations use to manage the patient intake process. From January 2016 until August 2020, Ms. Hoffman served as Chief Legal Officer and Chief Adm …
    NETWORK-1 TECHNOLOGIES, INC.Phreesia, Inc.·DEF 14A - NETWORK-1 TECHNOLOGIES, INC. --- DEFINITIVE PROXY STATEMENT·Q3 26·23 Jul
  • … od Pharmaceuticals Inc. Class A | 4,781,484 | 20,130 | | \* | Beta Bionics Inc. | 1,272,504 | 19,940 | | \*,1 | MapLight Therapeutics Inc. | 552,279 | 19,794 | | \* | Janux Therapeutics Inc. | 1,263,837 | 19,413 | | \* | <strong>Phreesia</strong> Inc. | 1,836,842 | 18,901 | | \*,1 | Aktis Oncology Inc. | 585,135 | 18,859 | | \*,1 | Immix Biopharma Inc. | 1,780,495 | 18,357 | | \* | Evolent Health Inc. Class A | 3,384,855 | 18,346 | | \* | Allogene Therapeutics In …
    バンガード・インデックス・ファンズPhreesia, Inc.·Interim Report - Semi-Annual Report (2026.01.01-2026.12.31)·30 Sep·29 Sep
  • … 50 | | | | PINTEREST INC | 13,995 | 24.790 | 346,936.050 | | | | FOX CORP-A | 2,272 | 64.300 | 146,089.600 | | | | DYNATRACE INC | 8,299 | 43.870 | 364,077.130 | | | | CLOUDFLARE INC | 830 | 193.990 | 161,011.700 | | | | <strong>PHREESIA</strong> INC | 2,472 | 20.280 | 50,132,160 | | | | FIVE9 INC | 7,235 | 19.070 | 137,971.450 | | | | GE HEALTHCARE TECHNOLOGIES INC. | 5,011 | 78.240 | 392,060.640 | | | | PROCORE TECHNOLOGIES INC | 8,704 | 72.170 | 628,167,680 | …
    アセットマネジメントOne株式会社Phreesia, Inc.·Prospectus - Securities registration statement·25 Aug·24 Aug
  • … elations and Corporate Communications. Ms. Goldstein previously served as the Company’s Senior Vice President of Finance from November 2003. Ms. Goldstein also serves as a director and member of the audit committee of <strong>Phreesia, Inc.</strong> | | | | Ms. Goldstein is a CPA with financial and business experience in the software, entertainment, retail and apparel industries, with proven success in managing the finance function of publicly traded companies. P …
    TAKE TWO INTERACTIVE SOFTWARE INCPhreesia, Inc.·DEF 14A - Definitive proxy statement·Q4 26·27 Jul
  • … elations and Corporate Communications. Ms. Goldstein previously served as the Company’s Senior Vice President of Finance from November 2003. Ms. Goldstein also serves as a director and member of the audit committee of <strong>Phreesia, Inc.</strong> | | | | Ms. Goldstein is a CPA with financial and business experience in the software, entertainment, retail and apparel industries, with proven success in managing the finance function of publicly traded companies. P …
    TAKE TWO INTERACTIVE SOFTWARE INCPhreesia, Inc.·PRE 14A - Preliminary proxy statement·Q4 26·17 Jul

Key Stats

Trading

Px/Chg 1D$10.07 / -2.80%
Avg Volume1.84M
Beta0.13
Mkt Cap622.45M
FD Mkt Cap746.38M

Float

Shrs Out/Float61.81M / 49.35M
Short Float0.07%
Days to Cover2.54
Stock Repurchased$0.00

Current Valuation

EV640.30M
EV/EBITDA15.09
EV/Sales1.29
P/B1.73
P/S1.26
FCF Yield2.79%
ROE0.83%
ROA0.44%
Current Ratio1.76

Estimates

P/E67.78
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgMay '23May '24May '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings77.25-8.94-8.49-227.55421.16210.07
Price / Sales6.235.603.2613.264.294.75
Price / Book Value3.795.474.625.491.621.73
Price / Free Cash Flow35.54-13.53-20.23158.0817.5435.87
ENTERPRISE VALUE METRICS
Enterprise Value1,019.21,406.71,087.21,387.6574.0640.3
Enterprise Value / Sales6.025.013.0512.654.524.89
Enterprise Value / EBITDA155.21-9.67-10.56647.81110.9937.46
Enterprise Value / EBIT-68.37-8.07-8.14-289.69-127.1191.18

Financials

Full Financials
Millions USD5Yr CAGR (%)Jan '22Jan '23Jan '24Jan '25Jan '26
INCOME STATEMENT
Revenue22.5%213.2280.9356.3419.8480.6
Gross Income25.4%131.8171.6232.3284.9326.5
EBITDA—-92.3-145.5-102.9-25.629.5
EBIT-63.9%-116.8-174.3-133.5-53.5-2.0
Net Income—-118.2-176.1-136.9-58.52.3
EPS (Diluted)—-2.37-3.36-2.51-1.020.04
BALANCE SHEET
Cash & ST Inv-30.4%313.8176.787.584.273.8
Total Assets7.6%494.5370.1370.3388.4663.8
Total Liabilities43.4%77.282.2118.9123.6326.6
Total Shareholder Equity-5.2%417.3287.8251.4264.8337.2
CASH FLOW
Net Operating Cash Flow—-74.7-90.1-32.432.478.8
Cap Ex-22.5%-30.8-26.2-25.1-24.1-11.1
Free Cash Flow—-105.5-116.3-57.58.367.7

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)12.70
Basic Shares61.81
Market Cap785.0
Diluted Shares62.04
Fully Diluted Shares Outstanding62.04
Fully Diluted Market Cap787.9
+Consolidated Debt92.6
−In-the-Money Convertible Debt—
+Capital Leases2.0
+Operating Leases—
−Cash & Equivalents-74.7
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value802.9

Segment data

Revenue

by Products and services

  • Subscription And Services46%
  • Network Solutions29%
  • Payment Solutions25%

Related companies

Visa Inc.

V US

Mastercard Inc

MA US

Alibaba Group Holding Ltd

BABA US

Delta Electronics, Inc.

2308 TT

Uber Technologies, Inc

UBER US

Keyence Corporation

KYCCF US

Accenture Public Limited Company

ACN US

Hon Hai Precision Industry Co., Ltd.

HNHPF US

Murata Manufacturing Co., Ltd.

MRAAY US

Venture Corporation Limited

VEMLY US

DoorDash, Inc.

DASH US

Unimicron Technology Corp.

3037 TT